Prostate Cancer - Results from #23060

Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: A prospective multi-center study - Abstract June 4, 2013

ASCO 2013 - Poster: Open-label, multicenter study of sipuleucel-T in men with metastatic castrate resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data June 3, 2013

Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement - Abstract June 3, 2013

Critical evaluation of MRI-targeted TRUS-guided transperineal fusion biopsy for detection of prostate cancer - Abstract June 3, 2013

Early post-operative urinary and sexual function predicts functional recovery at one year following prostatectomy - Abstract June 3, 2013

Prostate cancer overdiagnosis and overtreatment - Abstract June 3, 2013

Genetic markers associated with early cancer-specific mortality following prostatectomy - Abstract June 3, 2013

ASCO 2013 - Podcast: Open-label, multicenter study of sipuleucel-T in men with metastatic castrate resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data June 3, 2013

ASCO 2013 - Podcast: Evolving patterns of metastatic disease in castration-resistant prostate cancer (CRPC) reported in clinical trials from 1990 to 2011 June 3, 2013

Comparison of 3 different postimplant dosimetry methods following permanent (125)I prostate seed brachytherapy - Abstract June 3, 2013

Quality of life after prostate cancer treatments in patients comparable at baseline - Abstract June 3, 2013

Screening for prostate cancer in New Zealand general practice - Abstract June 3, 2013

Dormancy in solid tumors: Implications for prostate cancer - Abstract June 3, 2013

Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate - Abstract June 3, 2013

Consumption of fish products across the lifespan and prostate cancer risk - Abstract June 3, 2013

ASCO 2013 - Poster: Long-term safety and efficacy analysis of abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer without prior chemotherapy (COU-AA-302) June 1, 2013

ASCO 2013 - Poster: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Slide Presentation: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Slide Lecture: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Podcast: Long-term safety and efficacy analysis of abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer without prior chemotherapy (COU-AA-302) June 1, 2013

Page 1154 of 1436